In recent years, GLP-1 has made many important advances in a number of research areas, including the cardiovascular system, central nervous system, obesity and metabolic syndrome, insulin secretion, muscle and liver (Fig. 9). Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.